Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 53, 2023 - Issue 7-8
153
Views
0
CrossRef citations to date
0
Altmetric
Articles

Scalable synthesis of biologically active novel ethyl 1-(4-alkyl-3-oxo-3,4-dihydro quinoxaline-2-yl)-1H-pyrazole-4-carboxylate derivatives

, , , , , & show all
Pages 547-556 | Received 10 Oct 2022, Published online: 02 Mar 2023
 

Abstract

A one pot synthesis of ethyl 1-(1,2-dihydro-2-oxoquinoxalin-3-yl)-1H-pyrazole-4-carboxylate has been developed using the 3-hydrazineylquinoxalin-2(1H)-N-alkylation derivatizes one and ethyl 2-Formyl-3-oxopropionate and further this scaffold to afford the various novel ethyl 1-(4-Alkyl-3-oxo-3,4-dihydroquinoxalin-2-yl)-1H-pyrazole-4-carboxylate derivatives. The developed method is a novel, cost-effective, and industrially viable method. Consequently, the process described is less cumbersome due to the number of reaction stages reduced, the purity of the organic compound produced, and the substantial yield. This novel synthetic route is believed to be the shortest and most efficient of previous synthetic routes. The established route could be facilitated to prepare various key intermediates and active pharmaceutical ingredients.

GRAPHICAL ABSTRACT

Acknowledgments

We want to extend our deepest gratitude to Dr. Umamaheshwara for always being there for us when we needed assistance.

Additional information

Funding

Dr. Nagaraju Devunuri is thankful to DST-SERB TARE for funding (Project Grant No: TAR/2022/000339).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.